002004 Huapont Life Sciences
- 4.11
- +0.04+0.98%
Huapont Life Sciences News
Huabang Health (002004): Foreign Investment Rating Report (FIR)
First coverage of Huabang Health (002004): Promoting multi-field business layout
Huabang Health (002004) Review: Establishing a Medical Holding Subsidiary, Big Health's Layout Is Next
Huabang Health (002004) Interim Report Review: Single-quarter performance improved, overall gross margin increased
Huabang Health (002004): quarterly increase in performance and deepening of the layout of medical services
Huabang Health (002004) Annual Report Review: “Medicine” and “Medicine” Dual Engine Drive Optimism in the Field of Rehabilitation
Comments on Huabang Health (002004) Annual report: main business growth, stable expansion of rehabilitation medicine
Comments on Huabang Health (002004) Annual report: large Health Industry accelerates expansion of agrochemical business and spin-off listing
Huabang Health (002004) in-depth report: blockbuster products are expected to expand the healthy layout is imperative
Comments on Huabang Health (002004): the main business of medicine is growing rapidly and the rehabilitation plate is ready to start.
Huabang Health (002004) Research Brief: The main business is growing rapidly and rehabilitation medicine is progressing smoothly
Huabang Health (002004) Review: Plans to increase capital to advance the origin of life into cell therapy
Huabang Health (002004) Review: Acquiring the origin of life, rapid access to stem cell storage and application, and making every effort to promote the big health strategy
[Guoxin Securities] Huabang Health: Acquiring the origin of life, rapid access to stem cell storage and application, and making every effort to promote the big health strategy
Huabang Health Stock Code (002004) Review: Investing in the origin of life opens up the layout of the field of advanced medical technology
[Southwest Securities] Huabang Health: Plans to increase capital to Life Origin and advance into cell therapy
[Huachuang Securities] Huabang Health: Investing in the origin of life and opening up a layout in the field of advanced medical technology
Huabang Health (002004) Review: Proposed acquisition of some shares in Life Origin to improve the health industry chain
[Huatai Securities] Huabang Health: Proposes to acquire part of the shares in Life Origin to improve the health industry chain
Huabang Health (002004) Review: Proposed acquisition of Swiss Biotech's overseas presence continues to advance
Analysis
Price Target
No Data
